Lawson Macartney
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Dr. Lawson Macartney is a Senior Independent Non-Executive Director at Dechra Pharmaceuticals Ltd., an Independent Chairman at Viking Therapeutics, Inc. and a Member at Royal College of Veterinary Surgeons.
He is on the Board of Directors at Dechra Pharmaceuticals Ltd. and Netherlands Translational Research Center BV.
Dr. Macartney was previously employed as a Chief Executive Officer by Scout Bio, Inc., a President, Chief Executive Officer & Director by Ambrx, Inc., a Senior Vice President-Emerging Business Unit by Shire AG, a Vice President by Cardiovascular Group, a Vice President by Metabolic Research, Inc., a Senior Vice President-Global Product Strategy by GlaxoSmithKline Plc, and an Executive Director-Commercial Operations by Astra Merck, Inc. He received his undergraduate degree from the University of Glasgow School of Veterinary Medicine and a doctorate degree from the University of Glasgow.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-14 | 47,965 ( 0.04% ) | 2 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Chairman | 2015-04-30 |
| DECHRA PHARMACEUTICALS | Director/Board Member | 2016-11-30 |
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services Functions as the regulatory body for veterinary surgeons in the United Kingdom | Corporate Officer/Principal | - |
Netherlands Translational Research Center BV
Netherlands Translational Research Center BV Medical/Nursing ServicesHealth Services Develops small molecule drug leads and preclinical candidates for cancer, autoimmune and Parkinson diseases | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Scout Bio, Inc.
Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that specializes in veterinary, animal health and gene therapy | Chief Executive Officer | 2017-05-31 |
| AMBRX INC | Chief Executive Officer | 2015-05-31 |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | 2012-12-31 |
| GSK PLC | Corporate Officer/Principal | 2010-12-31 |
Cardiovascular Group
Cardiovascular Group Medical/Nursing ServicesHealth Services Provides cardiovascular services | Corporate Officer/Principal | 2006-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Metabolic Research, Inc.
Metabolic Research, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical-grade and non-synthetic pharmaceuticals | Health Technology |
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services Functions as the regulatory body for veterinary surgeons in the United Kingdom | Commercial Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Dechra Pharmaceuticals Ltd.
Dechra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells veterinary pharmaceuticals | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Ambrx, Inc.
Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Cardiovascular Group
Cardiovascular Group Medical/Nursing ServicesHealth Services Provides cardiovascular services | Health Services |
Netherlands Translational Research Center BV
Netherlands Translational Research Center BV Medical/Nursing ServicesHealth Services Develops small molecule drug leads and preclinical candidates for cancer, autoimmune and Parkinson diseases | Health Services |
Viking Therapeutics, Inc.
Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
University of Glasgow School of Veterinary Medicine
University of Glasgow School of Veterinary Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
Scout Bio, Inc.
Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that specializes in veterinary, animal health and gene therapy | Health Technology |
Select your edition
All financial news and data tailored to specific country editions